3 hours FY2024 EPS Estimates for Immunic Decreased by AnalystMarketBeat
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Research analysts at Brookline Capital Management reduced their FY2024 earnings per share estimates for shares of Immunic in a report released on Tuesday, October 15th. Brookline Capital Management analyst…
Earnings · Nasdaq 100 · Science
X